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A B S T R A C T
The avian IgY antibody isotype shares a common ancestor with both mammalian IgG and IgE and so
provides a means to study the evolution of their structural and functional specialisations. Although both
IgG and IgE bind to their leukocyte Fc receptorswith 1:1 stoichiometry, IgY binds to CHIR-AB1, a receptor
expressed in avian monocytes, with 2:1 stoichiometry. The mutagenesis data reported here explain the
structural basis for this difference, mapping the CHIR-AB1 binding site to the Cy3/Cy4 interface and not
the N-terminal region of Cy3 where, at equivalent locations, the IgG and IgE leukocyte Fc receptor
binding sites lie. This ﬁnding, together with the phylogenetic relationship of the antibodies and their
receptors, indicates that a substantial shift in the nature of Fc receptor binding occurred during the
evolution of mammalian IgG and IgE.
 2009 Elsevier Ltd.
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Interactions between the Fc region of immunoglobulins (Ig) and
membrane-bound Fc receptors on cells of the innate immune
system are key, isotype-speciﬁc events in the activation and
regulation of the vertebrate immune system. A wide variety of
immune responses may be tailored to a particular antigenic
challenge through control over which Ig isotype is secreted and
which Fc receptors are expressed on each cell type [1]. The
evolution of novel or improved functions in vertebrate adaptive
immune systems is therefore closely tied to the appearance and co-
evolution of new Ig isotypes and Fc receptors.
Birds and reptiles possess an Ig isotype called IgY, which is
functionally analogous to IgG of mammals: both are present in the
serum at high levels (10 mg/mL) and provide defence against
microbial infection. A duplication of the gene encoding an IgY-like
heavy chain occurred between 160 and 310 mya, during theAbbreviations: Ca/e/g/y, heavy chain constant domain of IgA/IgE/IgG/IgY; CHIR-
AB1, chicken leukocyte immunoglobulin-like receptor AB1; FcaR, the leukocyte
receptor for IgA (CD89); FcgRIII, a low afﬁnity receptor for IgG (CD16); FceRI, the
high-afﬁnity receptor for IgE; Fcy2–4, chicken IgY-Fc fragment containing heavy
chain constant domains 2, 3 and 4; MQ-NCSU, a chicken monocyte cell line;
sfpCHIR-AB1, soluble fusion protein of the extracellular region of CHIR-AB1 and
human IgG-Fc; SPR, surface plasmon resonance (Biacore).
* Corresponding author. Tel.: +44 0207 848 6496; fax: +44 0207 848 6435.
E-mail address: alexander.taylor@kcl.ac.uk (A.I. Taylor).
0145-305X  2009 Elsevier Ltd.
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Open access under CC BY license.evolution of mammals, and allowed the divergence of both IgG and
IgE [2,3], the latter of which is involved in anti-parasitic responses
and allergic hypersensitivity. As this did not occur in the bird/
reptile lineage, the ancestral isotype has been conserved;
comparative studies with IgY therefore offer a means to deduce
the evolutionary changes that have allowed IgG and IgE to adapt to
their different roles in modern species [4]. Although IgY is
functionally similar to IgG, its structure appears to have conserved
features of both IgG and IgE [5,6].
IgG and IgE have several leukocyte Fc receptors, most of which
are closely related (e.g. FcgRI-IV, FceRI); in humans, the classical Fc
receptor gene cluster (FcR) is found on chromosome 1, together
with a variety of related Fc receptor-like (FCRL) sequences that are
thought to be immunoregulatory receptors, but do not bind IgG or
IgE [7]. In birds, this cluster is represented by a single gene [8,9]
encoding a receptor-like molecule that does not bind IgY. Instead,
the leukocyte IgY-Fc receptors identiﬁed to date belong to a large
group of similar genes, chicken immunoglobulin-like receptors
(CHIR), which are homologous to the leukocyte receptor cluster
(LRC) on human chromosome 19, but only distantly related to FcR/
FCRL [10]. In order to reconcile the phylogeny of IgY, IgG and IgE
with that of their Fc receptors, we previously postulated that a
major evolutionary event must have occurred: the migration of Fc
receptor function from one gene family to another, perhaps driven
by selection pressure to evade microbial peptides that compete
with Fc receptor binding [6]. An ‘arms race’ of this sort has been
shown to drive diversiﬁcation of the leukocyte Fc receptor binding
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involved in mucosal immunity [11]. Although FcR/FCRL genes are
present in basal amphibians, phylogenetic analysis of the FcR/FCRL
gene cluster indicates that the non-Fc-binding FCRLs are the more
ancient members of the cluster [8,9,12], which supports a
relatively recent acquisition of Fc receptor function for this cluster
(i.e. mammalian FcRs appear to have evolved from non-Fc-binding
ancestors).
In order to further investigate what may therefore be a
primitive Fc receptor interaction, we have mapped the Fc receptor
binding site on an avian (chicken, Gallus gallus) IgY-Fc, using
mutagenesis to identify key amino acids involved in binding to an
avian monocyte cell line, MQ-NCSU [13], and to the soluble
extracellular region of CHIR-AB1, a high-afﬁnity activating IgY
receptor that is expressed on several avian leukocytes including
monocytes [14].
2. Materials and methods
2.1. Generation of mutant IgY-Fc fragments and soluble CHIR-AB1
A cDNA cassette encoding the Fcy2–4 fragment of chicken (G
gallus) IgY (residues 230–568), with an N-terminal signal peptide
to allow secretion, was cloned as described previously [6] and
ligated into pCEP4 (Invitrogen). Site-directed mutagenesis was
performed using Quikchange (Stratagene). Plasmids were tran-
siently transfected into HEK293E cells using TransIT (Mirus Bio)
and culturemedium supplemented with 0.2 mg/mL Hygromycin B
(Invitrogen) to effect selection. Secreted IgY-Fc fragments were
isolated from the cell culture medium using anti-IgY-Fc-agarose
(Immunology Consultants Laboratory) and further puriﬁed by size
exclusion chromatography using Superdex 200 (GE Life Sciences),
as described previously [6]. sfpCHIR-AB1, a soluble fusion protein
consisting of the extracellular domain of CHIR-AB1 and the Fc
region of human IgG1 [14], was prepared using the above
expression system, as described previously [15].
2.2. Flow cytometry (FACS) analysis of mutant IgY-Fc fragments
binding to monocytes
Chicken MQ-NCSU monocytes [13] were assayed for IgY-Fc
binding as described previously [5]. Brieﬂy, cells were incubated
with puriﬁed IgY-Fc mutants (10 nM, saturating for wild-type at
4 8C) or buffer (phosphate-buffered saline with 1% BSA) alone for
1 h, then stained with mouse monoclonal anti-IgY-Fc (Cy2-Fig. 1. Space-ﬁlling diagrams showing the Fc fragments (yellow) of human IgA (A), IgE (
FcgRIII, respectively, and two orthogonal views (D and E) of chicken IgY-Fc (domains Cy
Fcy3–4 for display purposes, although these residues were found to be disordered [5]. C
study. Residues whose mutation had no effect are coloured green and labelled in (D);
monocytes are coloured red and labelled in (E).speciﬁc) antibodies (Sigma) and anti-mouse-IgG-FITC (Dako)
sequentially, with prior washes. Cells were analysed using a
FACSCalibur instrument (BD Biosciences).
2.3. SPR analysis of mutant IgY-Fc fragments binding to CHIR-AB1
IgY-Fc binding to sfpCHIR was assayed as described previously
[15]. Brieﬂy, 90RU of puriﬁed sfpCHIR-AB1 were immobilised on
a CM5 sensor surface and binding of puriﬁed IgY-Fc (Fcy2–4)
mutants (25–400 nM) was measured using a Biacore 3000
instrument. Association rate constants (kon), dissociation rate
constants (koff) and equilibrium association constants (KA) were
obtained by ﬁtting with a 1:1 binding model.
3. Results and discussion
Previous research has suggested that interactions between
avian IgY and its Fc receptorsmay bemore similar to that of human
IgA and its leukocyte Fc receptor, FcaR, than the equivalent
interactions between IgG and IgE and their leukocyte Fc receptors;
both FcaR and CHIR-AB1 are encoded in the LRC, their Fc-binding
domains are structurally homologous (rmsd = 1.9 A˚) and soluble
monomeric versions of each have been found to bind to their
ligands with 2:1 stoichiometry [15,16]. By contrast, the leukocyte
receptors for both IgG and IgE bind with 1:1 stoichiometry. The
structural basis of this difference has been revealed by the location
of the Fc receptor binding site in each isotype [17]; the binding site
for FcaRI in IgA-Fc lies at the interface of the Ca2 and Ca3 domains
(Fig. 1A), whereas both IgE-Fc and IgG-Fc engage their leukocyte
receptors in similar locations close to the N-termini of the
homologous Ce3 and Cg2 domains, respectively (Fig. 1B and C).
In order to investigate whether the equivalent of either region in
IgY-Fc is the location of an Fc receptor binding site, candidate
receptor binding residues were selected for mutation by examining
the crystal structures of chicken IgY-Fc (PDB ID 2W59) and CHIR-
AB1 (PDB ID2VSD), superposedonthecomplexesof IgA-Fc, IgG-Fcor
IgE-Fc bound to FcaRI (PDB ID 1OW0), FcgRIII (PDB 1T83) and FceRI
(PDB ID 1O0V), respectively. To limit the number of candidate
residues, those conserved between IgY and IgG and/or IgE were
ignored as neither IgG nor IgE bind to avian monocytes [18]. All
residues were mutated individually, except 346–349 inclusive and
437/440, which were mutated together, for reasons of practicality.
The locations of the mutated residues are shown in Fig. 1D and E.
The results show that mutations made close to the Cy3
N-terminus had little or no effect on binding to either monocytesB) and IgG (C) in complex with their leukocyte Fc receptors (blue), FcaRI, FceRI and
3 and Cy4). Residues 346–348 were modelled onto the crystal structure of chicken
y2 domains are not shown, although they were included in the IgY-Fc used in this
residues whose mutation inhibited binding to soluble CHIR-AB1 and/or MQ-NCSU
Fig. 2. FACS histograms showing binding of chicken IgY-Fc mutants to chicken monocytes. MQ-NCSU cells were incubated with IgY-Fc (Fcy2–4) fragments containing the
mutations shown (ﬁlled peaks), or buffer alone (unﬁlled peaks), then stained for bound IgY-Fc (see Section 2).
Table 1
SPR measurements of recombinant IgY-Fc mutants binding to soluble CHIR-AB1.
IgY-Fc mutations kon (M
1 s1) koff (s
1) KA (M
1)
wt 3.0105 2.1103 1.4108
S346/C347P/S348R/P349G 4.2105 4.4103 9.5107
N376D 4.1105 2.1103 2.0108
E437H/L440R 3.8105 2.1103 1.8108
wta 2.6105 1.2103 2.1108
L366K NDb NDb NDb
R490E 2.3105 5.1104 4.5108
H495E 1.7105 1.5103 1.1108
R496E 2.2105 1.3103 1.8108
R556E 1.1104 1.1103 9.3106
F557R 9.2105 0.013 7.3107
a Wild-type Fcy2–4 was re-measured immediately before the indicated mutants
were run.
b Immeasurable as maximum binding was 1RU.
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of L366, H495, R556 or F557, all of which lie close to the interface
between Cy3 and Cy4 in the crystal structure of IgY-Fc, was found
to markedly disturb binding to monocytes. Binding to soluble
CHIR-AB1 was also affected by these mutations (note the severely
reduced binding for L366K and R556E, and markedly enhanced
dissociation rate for F557R, reﬂected in the grossly different shapes
of the traces in Fig. 3B), with the exception of H495E, whichFig. 3. SPR sensorgrams showing binding of chicken IgY-Fc mutants to soluble chicken CH
AB1, a soluble fusion protein consisting of the extracellular domain of CHIR-AB1 and the
shown as follows: (A) wild-type (black), S346D/C347P/S348R/P349G (red), N376D (gree
(blue), R496E (cyan), R556E (magenta), F557R (yellow).appeared to have wild-type binding kinetics. As the diminished
binding of IgY-Fc H495E to monocytes cannot be accounted for by
abrogated binding to CHIR-AB1, yet incubationwith excess soluble
CHIR-AB1 can block IgY-Fc binding to monocytes [15], this
suggests the presence of other high-afﬁnity Fc receptors with
binding sites that overlap that of CHIR-AB1 on avian monocytes.
Viertlboeck et al. have recently described several novel IgY-Fc
receptors that are highly similar to CHIR-AB1, although their
expression patterns are currently unknown [19]. Our results show
that the location of the IgY-Fc binding site for avian Fc receptors on
monocytes, including CHIR-AB1, lies in a similar region to the
binding site for FcaRI in IgA-Fc and not in the equivalent region to
the FcR binding sites in IgG or IgE.
Although it is possible that any mutation may have an
unforeseen allosteric effect as, for example, occurs when residues
in or close to the EF or AB helices in the Ce3 domains of IgE-Fc
(which lie at the Ce3/Ce4 interface and do not make direct contact
with receptor) are non-conservatively mutated [20,21], the
blocking mutations identiﬁed in the present study covered a
broad surface area and included conservative substitutions which,
in the case of the IgE-Fc studies, was sufﬁcient to eliminate ‘false-
positives’, i.e. mutations that affected receptor binding despite
lying outside the binding site [22].
The majority of the receptor contacts in IgA-Fc are found in the
Ca3 FG loop, CC0 loop and the Ca2 AB helix [23]; the homologous
structures in IgY-Fc also appear to be involved in binding to IgY-FcIR-AB1. IgY-Fc (Fcy2–4) fragments were tested on a CM5 chip coated with sfpCHIR-
Fc region of human IgG1 [14]. Data obtained for 400 nM of each IgY-Fc mutant are
n), E437H/L440R (blue); (B) wild-type (black), L366K (red), R490E (green), H495E
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bird and reptile IgY sequences in the literature (Supplementary
Fig. 1), which suggests that similarly interacting CHIR-AB1
orthologues may be present in these species. Despite such
widespread conservation between chicken and duck IgY
sequences, duck IgY fails to bind to chicken CHIR-AB1 [14].
However, this is likely due to a single amino acid difference
between the duck and chicken Cy3 AB helix, rather than a
completely different mode of interaction; the duck sequence
contains an arginine at a position adjacent to that of leucine 366 in
the chicken, one of the residues which, when substituted for a
charged residue (lysine), was found to prevent binding to both
monocytes and soluble CHIR-AB1 entirely (Figs. 2 and 3). It is
therefore likely that both chicken and duck IgY interact
with their respective receptors in a broadly similar manner: the
positive residue in the duck sequence being accommodated by a
complementary site in the duck receptor, whilst other pairings
remain identical. However, more substantial differences in the
mode of interaction cannot be ruled out. In order to investigate the
likelihood that the interaction between IgY and its leukocyte
receptor(s) predates the divergence of the bird/reptile class, all
available amphibian IgY sequences were also compared with
chicken IgY, but were found to be poorly conserved in the receptor
binding regions identiﬁed above (Supplementary Fig. 1). This
divergence may be due to the evolutionary distance between birds
and amphibians or reﬂect the different (predominantly mucosal)
functions served by IgY and its receptors in amphibians [24].
The ﬁndings reported here are consistent with the 2:1
stoichiometry for monomeric CHIR-AB1 reported previously [15]
and explain the lack of involvement of intra-heavy chain
disulphide bonds [18], the Cy2 domains [6] and N-linked
glycosylation [5] in binding to avian monocytes. By contrast,
similar studies of mammalian IgG and IgE have shown that the
equivalent structural features are crucial to the mechanics of their
receptor interactions: in IgE, intra-heavy chain disulphide bonds
[25] and the Ce2 domains [26] are required to establish the
exceptionally slow off-rate that leads to sensitisation of mast cells
and basophils; in IgG, complex-typeN-linked oligosaccharides that
lie between the Cg2 domains affect the structure of IgG-Fc and the
afﬁnity of FcgR interactions [27,28], which in turn modulates the
effector response [29]. The involvement of these structural
features in the functions of IgE and IgG is dependent on the
location of their Fc receptor binding sites, which are similar in both
mammalian isotypes (Fig. 1B and C), yet, as the results presented
here show, substantially different in IgY.
Our results provide evidence for a major shift in the mode of Fc
receptor binding during the evolution of vertebrate immunoglo-
bulins and show how various structural features of antibody Fc
regions (e.g. inter-chain disulphide bonds and glycosylation) may
have been co-opted to provide novel functions during the
evolution of IgG and IgE in mammals. From a strict Darwinian
perspective, the abrupt acquisition of a novel receptor and binding
site seems highly unorthodox; natura non facit saltum. However,
our understanding of the evolution of protein–protein interaction
networks, although still in its infancy, has revealed that enzymes
can evolve novel or improved substrate speciﬁcity by capitalising
on weak promiscuous interactions [30], which typically arise from
neutral genetic drift. Should this principle apply to the proteins of
the immune system, it would present a hitherto unappreciated
evolutionary mechanism by which proteins may rapidly be
co-opted for novel functions, and interaction networks ‘rewired’
to evade interfering proteins of microbial origin. In the case of
mammalian IgE and IgG, such rewiring, i.e. migration of receptor
binding activity to a site in the N-terminal region of Cg2/Ce3, as
well as interaction with a member of a different receptor family,
appears to have been a key step that occurred prior to theirdivergence from an IgY-like ancestor and subsequently allowed
existing structural features to be co-opted to novel roles as the
antibodies diverged and their current specialisations evolved.
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